BioSpace News Archive

Deals

electroCore Provides Business Update and Select Financial Guidance

electroCore, Inc. provided an update on its commercial operations, clinical development programs, and introduced select preliminary unaudited guidance for the fourth quarter of 2019, and full-year revenue guidance for 2020.

January 13, 2020
·
10 min read
Business

Misonix Reports Preliminary Fiscal 2020 Second Quarter Revenue of Approximately $19.7 MillionReiterates Expectation for Fiscal 2020 Full Year Pro Forma Revenue Growth of 20%

Misonix, Inc. announced preliminary unaudited fiscal 2020 second quarter revenue for the three months ended December 31, 2019 of approximately $19.7 million.

January 13, 2020
·
4 min read
Biotech Bay

Vir Biotechnology to Provide Pipeline Update at 38th Annual J.P. Morgan Healthcare Conference

Vir Biotechnology, Inc., a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases, will present tomorrow, January 14th, at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco..

January 13, 2020
·
7 min read
Business

iCAD Appoints Nathaniel Dalton to its Board of Directors

iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, announced Nathaniel Dalton was appointed to its Board of Directors.

January 13, 2020
·
3 min read
Deals

Kiniksa Announces Pipeline Progress and Reiterates 2020 Clinical Data Readouts

Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients with significant unmet medical need, announced recent pipeline progress and upcoming 2020 clinical milestones.

January 13, 2020
·
10 min read
Drug Development

Aravive Receives IND Clearance for Phase 1b/Phase 2 Clinical Trial of AVB-500 in Patients with Clear Cell Renal Cell Carcinoma

Aravive, Inc., a clinical-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration has cleared the company’s Investigational New Drug application for investigation of the company’s lead candidate, AVB-500, for the treatment of clear cell renal cell carcinoma.

January 13, 2020
·
6 min read
Business

MRI Interventions, Inc. To Change Corporate Name to ClearPoint Neuro, Inc.

MRI Interventions, Inc., a leading platform neurosurgery company, announced plans to change its corporate name to ClearPoint Neuro, Inc.

January 13, 2020
·
4 min read
Drug Development

Spero Reports Preliminary Findings from Phase 1 Clinical Trial of SPR206 and Plans to Advance Program with Alliance Partners Everest Medicines and the Department of Defense

First indication of human safety and pharmacokinetic profiles for SPR206 supports advancement of program to clinical pharmacology studies planned to initiate in the second half of 2020

January 13, 2020
·
9 min read
Deals

R1 Announces Agreement to Acquire SCI Solutions, a Leading Provider of Digital Patient Engagement Solutions

Acquisition adds robust digital front door capabilities to R1’s technology platform, enabling healthcare providers to automate ordering, scheduling, and authorization processes

January 13, 2020
·
5 min read
Tetra Bio-Pharma Receives Favorable Letter of Advice from USA FDA for QIXLEEF

Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, today announced that it has received a favorable Letter of Advice from the US Food and Drug Administration for QIXLEEF.

January 13, 2020
·
5 min read